Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.21.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The tables below present financial information for the Company’s two operating business segments.
Three Months Ended
March 31,
Revenues:
2021 2020
Corporate clinics
$ 9,470,860  $ 7,294,295 
Franchise operations
8,077,105  6,350,191 
Total revenues
$ 17,547,965  $ 13,644,486 
Depreciation and amortization:
Corporate clinics 1,093,833  577,543 
Franchise operations 342  342 
Corporate administration 75,691  76,364 
Total depreciation and amortization $ 1,169,866  $ 654,249 
Segment operating income:
Corporate clinics
$ 1,349,057  $ 783,706 
Franchise operations
3,847,773  2,844,298 
Total segment operating income
$ 5,196,830  $ 3,628,004 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 5,196,830  $ 3,628,004 
Unallocated corporate
(3,225,154) (2,874,654)
Consolidated income from operations 1,971,676  753,350 
Other expense, net 21,537  4,337 
Income before income tax benefit $ 1,950,139  $ 749,013 
Reconciliation of Assets from Segment to Consolidated
Segment assets: March 31,
2021
December 31,
2020
Corporate clinics $ 27,788,949  $ 24,928,311 
Franchise operations 10,192,465 9,744,375
Total segment assets 37,981,414 34,672,686
Unallocated cash and cash equivalents and restricted cash 18,007,150 20,819,629
Unallocated property and equipment 999,468 1,063,815
Other unallocated assets 9,919,527 9,176,713
Total assets $ 66,907,559  $ 65,732,843